-
1
-
-
17644416461
-
Epidemiology of gastroesophageal reflux disease: A systematic review
-
Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2005;54: 710-717.
-
(2005)
Gut
, vol.54
, pp. 710-717
-
-
Dent, J.1
El-Serag, H.B.2
Wallander, M.A.3
-
2
-
-
0030715691
-
Endoscopy-negative acid reflux disease
-
Smout AJPM. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther. 1997;11:81-85.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 81-85
-
-
Smout, A.J.P.M.1
-
3
-
-
0346734217
-
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study
-
Miner PJ, Katz PO, Chen Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol. 2003;98: 2616-2620.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2616-2620
-
-
Miner, P.J.1
Katz, P.O.2
Chen, Y.3
-
4
-
-
0032977314
-
Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole
-
Havelund T, Lind T, Wiklund I, et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol. 1999;94:1782-1789.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1782-1789
-
-
Havelund, T.1
Lind, T.2
Wiklund, I.3
-
5
-
-
0036865694
-
Persistent acid reflux and symptoms in patients with Barrett's esophagus on proton-pump inhibitor therapy
-
Basu KK, Bale R, West KP, et al. Persistent acid reflux and symptoms in patients with Barrett's esophagus on proton-pump inhibitor therapy. Eur J Gastroenterol Hepatol. 2002;14:1187-1192.
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, pp. 1187-1192
-
-
Basu, K.K.1
Bale, R.2
West, K.P.3
-
6
-
-
0030947026
-
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
-
Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol. 1997;92: 582-585.
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 582-585
-
-
Sharma, P.1
Sampliner, R.E.2
Camargo, E.3
-
7
-
-
0028216695
-
Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus
-
Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol. 1994;89:989-991.
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 989-991
-
-
Katzka, D.A.1
Castell, D.O.2
-
8
-
-
0034092949
-
Failure of esophageal acid control in candidates for Barrett's esophagus reversal on a very high dose of proton pump inhibitors
-
Fass R, Sampliner RE, Malagon IB, et al. Failure of esophageal acid control in candidates for Barrett's esophagus reversal on a very high dose of proton pump inhibitors. Aliment Pharmacol Ther. 2000;14: 597-602.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 597-602
-
-
Fass, R.1
Sampliner, R.E.2
Malagon, I.B.3
-
9
-
-
4644294046
-
Esophageal and gastric pH profiles in patients with gastroesophageal reflux disease and Barrett's esophagus treated with proton pump inhibitors
-
Gerson LB, Boparai V, Ullah N, et al. Esophageal and gastric pH profiles in patients with gastroesophageal reflux disease and Barrett's esophagus treated with proton pump inhibitors. Aliment Pharmacol Ther. 2004;20:637-643.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 637-643
-
-
Gerson, L.B.1
Boparai, V.2
Ullah, N.3
-
10
-
-
33745401257
-
Intra-esophageal acid suppression in complicated gastroesophageal reflux disease: Esomeprazole versus lansoprazole
-
Frazzoni M, Manno M, De Micheli E, et al. Intra-esophageal acid suppression in complicated gastroesophageal reflux disease: esomeprazole versus lansoprazole. Dig Liv Dis. 2006;38:85-90.
-
(2006)
Dig Liv Dis
, vol.38
, pp. 85-90
-
-
Frazzoni, M.1
Manno, M.2
De Micheli, E.3
-
11
-
-
3142708981
-
Complete elimination of reflux symptoms does not guarantee normalization of intraesopha- geal and intragastric pH in patients with gastroesophageal reflux disease
-
Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesopha- geal and intragastric pH in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2004;99:991-996.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 991-996
-
-
Milkes, D.1
Gerson, L.B.2
Triadafilopoulos, G.3
-
12
-
-
8744230588
-
Relationship between symptom response and esophageal acid exposure after medical and surgical treatment for gastroesophageal reflux disease
-
Jenkinson AD, Kadirkamanathan SS, Scott SM, et al. Relationship between symptom response and esophageal acid exposure after medical and surgical treatment for gastroesophageal reflux disease. Br J Surg. 2004;91:1460-1465.
-
(2004)
Br J Surg
, vol.91
, pp. 1460-1465
-
-
Jenkinson, A.D.1
Kadirkamanathan, S.S.2
Scott, S.M.3
-
13
-
-
0036205918
-
-
Penagini R, Cantu P, Mangano M, et al. Long-term effects of pneumatic dilatation on symptoms and lower esophageal sphincter pressure in achalasia. Scand J Gastroenterol. 2002;37:380-384.14. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992;87:1102-1111.
-
Penagini R, Cantu P, Mangano M, et al. Long-term effects of pneumatic dilatation on symptoms and lower esophageal sphincter pressure in achalasia. Scand J Gastroenterol. 2002;37:380-384.14. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992;87:1102-1111.
-
-
-
-
14
-
-
0031787618
-
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
-
Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998;115:1335-1339.
-
(1998)
Gastroenterology
, vol.115
, pp. 1335-1339
-
-
Peghini, P.L.1
Katz, P.O.2
Castell, D.O.3
-
15
-
-
0029938339
-
Relation between esophageal acid exposure and healing of esophagitis with omeprazole in patients with severe reflux esophagitis
-
Holloway RH, Dent J, Narielvala F, et al. Relation between esophageal acid exposure and healing of esophagitis with omeprazole in patients with severe reflux esophagitis. Gut. 1996;38:649-654.
-
(1996)
Gut
, vol.38
, pp. 649-654
-
-
Holloway, R.H.1
Dent, J.2
Narielvala, F.3
-
16
-
-
13944282644
-
The role of esophageal pH monitoring in symptomatic patients on PPI therapy
-
Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100:283-289.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 283-289
-
-
Charbel, S.1
Khandwala, F.2
Vaezi, M.F.3
-
17
-
-
0347002479
-
Sufficient control of heartburn in endoscopy-negative gastroesophageal reflux disease trials
-
Junghard O, Carlsson R, Lind T. Sufficient control of heartburn in endoscopy-negative gastroesophageal reflux disease trials. Scand J Gastroenterol. 2003;12:1197-1199.
-
(2003)
Scand J Gastroenterol
, vol.12
, pp. 1197-1199
-
-
Junghard, O.1
Carlsson, R.2
Lind, T.3
-
18
-
-
0033011401
-
Factors influencing compliance in long-term proton pump inhibitor therapy in general practice
-
Hungin APS, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract. 1999;49:463-464.
-
(1999)
Br J Gen Pract
, vol.49
, pp. 463-464
-
-
Hungin, A.P.S.1
Rubin, G.2
O'Flanagan, H.3
-
19
-
-
0036020526
-
Proton pump inhibitors-differences emerge in hepatic metabolism
-
McColl KEL, Kennerley P. Proton pump inhibitors-differences emerge in hepatic metabolism. Dig Liver Dis. 2002;34:461-467.
-
(2002)
Dig Liver Dis
, vol.34
, pp. 461-467
-
-
McColl, K.E.L.1
Kennerley, P.2
-
20
-
-
32044464312
-
Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux
-
Bredenoord AJ, Weusten BLAM, Timmer R, et al. Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology. 2006;130: 334-340.
-
(2006)
Gastroenterology
, vol.130
, pp. 334-340
-
-
Bredenoord, A.J.1
Weusten, B.L.A.M.2
Timmer, R.3
-
21
-
-
25444529459
-
Extraesophageal manifestations of gastroesophageal reflux
-
Poelmans J, Tack J. Extraesophageal manifestations of gastroesophageal reflux. Gut. 2005;54:1492-1499.
-
(2005)
Gut
, vol.54
, pp. 1492-1499
-
-
Poelmans, J.1
Tack, J.2
|